Mesmerise Group

London, UKFounded 201651–100 employeesmesmerisegroup.comLinkedIn

Mesmerise Group works with extended reality (XR) to create immersive experiences for collaboration and medical education. Its work spans enterprise use cases, including a collaboration with TD, and healthcare initiatives involving AI and XR.

Visit mesmerisegroup.com ↗

Founded: 2016
Employees: 51–100

reccy insights

Written by reccy's AI from company sites, press and funding records · updated Oct 2026

Recent highlights

Mesmerise’s clearest recent product milestone is the call-to-sale attribution system announced on Aug 28, 2026 under the Mesmerise Digital name. It links inbound phone conversations to the campaigns that generated them, using consent-based recording and transcription alongside campaign data to help businesses attribute phone-driven conversions and revenue. Earlier, on Jan 14, 2025, Mesmerise announced a collaboration with Mayo Clinic to develop NeuRealities, a medical education and healthcare workforce training platform combining Mayo Clinic’s clinical expertise with Mesmerise’s AI-powered spatial computing. The partnership was also covered on Jan 16, 2025. The company’s leadership announcements include Leslie Marshall’s appointment as Chief Marketing Officer on Jan 26, 2023 and Dan Donovan’s appointment as Chief Technology Officer on Aug 8, 2023. These milestones show activity across two distinct applications: immersive healthcare education and marketing attribution. The company’s 2018 seed round is the only recorded funding round in the available profile, and its amount is undisclosed.

Market position

Mesmerise operates at the intersection of extended reality, enterprise software, and immersive healthcare education. Its stated offer spans virtual, augmented, and mixed reality experiences, while its Mayo Clinic collaboration adds a specialized medical education use case: NeuRealities combines clinical expertise with AI-powered spatial computing for education and workforce training. Its website positioning also emphasizes immersive collaboration as an alternative to conventional video conferencing, with enterprise experience that includes TD. The 2026 call-to-sale attribution launch broadens its activity beyond XR into marketing measurement, so the business profile is not limited to immersive content or gaming. The available company information does not establish a reliable set of distinct, named competitors; naming specific rivals would therefore be speculative. At a category level, it competes for enterprise XR and immersive-learning projects with providers of virtual training, collaboration, and spatial-computing solutions, while the attribution product enters a separate marketing analytics arena. Its Mayo Clinic relationship and combination of AI with spatial computing are identifiable differentiators in healthcare education, but public evidence here does not quantify adoption, revenue, or market share against peers.

Growth & opportunities

The long gap between that financing record and later milestones means funding history alone does not demonstrate a continuous expansion curve. Product and partnership activity does indicate a widening set of applications. The Jan 14, 2025 Mayo Clinic collaboration brought the company’s AI and spatial-computing capabilities into medical education and healthcare workforce training through NeuRealities. On Aug 28, 2026, Mesmerise announced a call-to-sale attribution system, extending its product activity into campaign measurement using consent-based call recording, transcription, and marketing data. These launches represent two distinct growth directions—specialized immersive learning and business-focused attribution—rather than a single, clearly documented product scaling sequence.

Written by reccy's AI from company sites, press and funding records · updated Oct 2026

What makes Mesmerise Group distinct

reccy insights

What makes Mesmerise Group distinct

01Uses extended reality to create immersive, inclusive collaboration experiences beyond conventional video conferencing.
02Applies AI and XR to medical education and healthcare workforce training.
03Has enterprise collaboration experience, including work involving TD.
04Collaborates with Mayo Clinic on NeuRealities, a digital medical education initiative.

Technology & products4

Technology & products

XR Solutions
Develops and implements extended reality solutions, including virtual, augmented, and mixed reality, to create immersive environments for businesses.
AI Solutions
AI-driven solutions designed to support decision-making, automate processes, and develop business models while managing associated risks.
Discovery & Design
A structured approach to identifying opportunities and creating a business-specific roadmap for AI and XR integration.
Call-to-Sale Attribution System
Connects inbound phone conversations with the marketing campaigns that generated them.

Show all 4 products

+ 1 more: Call-to-Sale Attribution System

Recent updates3

Launches, partnerships and team changes from press coverage

Aug 1, 2026Product launch
Mesmerise Digital launched a call-to-sale attribution system that links inbound phone conversations to the marketing campaigns that generated them. It combines consent-based call recording and transcription with campaign data to help clients attribute phone-driven conversions and revenue.
newsfilecorp.com
Jan 14, 2025Partnership
NeuRealities will combine Mayo Clinic’s clinical expertise with Mesmerise’s AI-powered spatial computing to create a digital platform for medical education.
businesswireindia.com
Jan 26, 2023Team change
Leslie Marshall was appointed Chief Marketing Officer.
prnewswire.co.uk

About Mesmerise Group

Products: XR Solutions, AI Solutions, Discovery & Design, Call-to-Sale Attribution System
Leadership: Andrew Hawken, Co-Founder and CEOScott Colebourn, Head of Delivery and EngineeringHasan Siber, Director of OperationsMichael Dutton, Senior Vice President, Content Partnerships and Strategy
Focus areas: Extended reality, virtual reality, artificial intelligence, enterprise collaboration, healthcare, medical education, immersive technology
Headquarters: London, UK
Founded: 2016
Employees: 51–100
Patents granted: 1 (Crunchbase)